918631-01-3 Usage
Uses
Used in Organic Chemistry:
2,4(1H,3H)-Pyrimidinedione, 6-methyl-5-[(phenylmethoxy)methyl]-1,3-bis(phenylmethyl)is used as a building block or intermediate in the synthesis of more complex organic compounds. Its unique structural features, such as the 6-methyl-5-[(phenylmethoxy)methyl] group and the 1,3-bis(phenylmethyl) moiety, make it a valuable component in the development of novel organic molecules with specific properties and functions.
Used in Pharmaceutical Industry:
2,4(1H,3H)-Pyrimidinedione, 6-methyl-5-[(phenylmethoxy)methyl]-1,3-bis(phenylmethyl)is used as a potential drug candidate or a precursor in the development of new pharmaceutical agents. Its unique structural features may provide opportunities for the design of novel therapeutic agents with improved efficacy, selectivity, and safety profiles. Further research and development are required to explore its potential applications in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 918631-01-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,6,3 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 918631-01:
(8*9)+(7*1)+(6*8)+(5*6)+(4*3)+(3*1)+(2*0)+(1*1)=173
173 % 10 = 3
So 918631-01-3 is a valid CAS Registry Number.
918631-01-3Relevant academic research and scientific papers
Synthesis of l-(alkoxymethyl)-5-benzyl-6-methyluracil as potential nonnucleoside HIV-1 RT inhibitors
Chen, Yanli,Guo, Ying,Yang, Hua,Wang, Xiaowei,Liu, Junyi
, p. 2913 - 2920 (2007/10/03)
1,3-Dibenzyl-6-methyl-5-zincbromomethyluracil 6 was prepared starting from 6-methyluracil 1. The cross-coupling reaction of benzylic zinc reagent 6 with PhI using bis(dibenzylideneacetone) palladium(0) and (o-furyl)3P as catalyst gave 1,3,5-tribenzyl-6-methyluracil 7. The N-1,N-3-dibenzyl group could be removed in dealkylation to give the 5-benzyl-6-methyluracil 8. It was N-1-alkylated with chloromethyl ethyl ether or chloromethyl benzyl ether to obtained the targets 9a and b. All synthesized compounds were tested for their inhibition of HIV-1 reverse transcriptase, and moderate activity were found for target compounds 9a and b and 5. Copyright Taylor & Francis Group, LLC.
